BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23358872)

  • 1. The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1.
    Li Y; Chen X; Wang Z; Zhao D; Chen H; Chen W; Zhou Z; Zhang J; Zhang J; Li H; Chen C
    Neoplasia; 2013 Jan; 15(1):39-48. PubMed ID: 23358872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
    Cho JJ; Xu Z; Parthasarathy U; Drashansky TT; Helm EY; Zuniga AN; Lorentsen KJ; Mansouri S; Cho JY; Edelmann MJ; Duong DM; Gehring T; Seeholzer T; Krappmann D; Uddin MN; Califano D; Wang RL; Jin L; Li H; Lv D; Zhou D; Zhou L; Avram D
    Nat Commun; 2019 Feb; 10(1):701. PubMed ID: 30741923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8.
    Li Y; Kong Y; Zhou Z; Chen H; Wang Z; Hsieh YC; Zhao D; Zhi X; Huang J; Zhang J; Li H; Chen C
    Cell Death Dis; 2013 Nov; 4(11):e935. PubMed ID: 24287696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.
    Li Y; Wu X; Li L; Liu Y; Xu C; Su D; Liu Z
    Cancer Lett; 2017 Sep; 404():44-52. PubMed ID: 28716524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara.
    Yu J; Lan J; Zhu Y; Li X; Lai X; Xue Y; Jin C; Huang H
    Biochem Biophys Res Commun; 2008 Mar; 367(4):805-12. PubMed ID: 18194665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.
    Wu X; Li L; Li Y; Liu Z
    Am J Cancer Res; 2016; 6(7):1563-71. PubMed ID: 27508098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
    Huang F; Huang Z; Wei Q; Liu G; Pu J
    Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between syntaxin 8 and HECTd3, a HECT domain ligase.
    Zhang L; Kang L; Bond W; Zhang N
    Cell Mol Neurobiol; 2009 Feb; 29(1):115-21. PubMed ID: 18821010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
    Oeckinghaus A; Wegener E; Welteke V; Ferch U; Arslan SC; Ruland J; Scheidereit C; Krappmann D
    EMBO J; 2007 Nov; 26(22):4634-45. PubMed ID: 17948050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.
    Jiang Q; Li F; Cheng Z; Kong Y; Chen C
    Cell Mol Life Sci; 2020 Apr; 77(8):1483-1495. PubMed ID: 31637449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HECTD3 promotes NLRP3 inflammasome and pyroptosis to exacerbate diabetes-related cognitive impairment by stabilising MALT1 to regulate JNK pathway.
    Ruan Z; Li Y; Chen Y
    Arch Physiol Biochem; 2022 Aug; ():1-12. PubMed ID: 35913790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.
    Pelzer C; Cabalzar K; Wolf A; Gonzalez M; Lenz G; Thome M
    Nat Immunol; 2013 Apr; 14(4):337-45. PubMed ID: 23416615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
    Jeon YK; Kim CK; Koh J; Chung DH; Ha GH
    Oncotarget; 2016 Jul; 7(27):41811-41824. PubMed ID: 27248820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma.
    Nagel D; Bognar M; Eitelhuber AC; Kutzner K; Vincendeau M; Krappmann D
    Oncotarget; 2015 Dec; 6(39):42232-42. PubMed ID: 26540570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
    Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
    Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
    Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
    Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.
    Shu T; Li Y; Wu X; Li B; Liu Z
    Cancer Lett; 2017 Dec; 411():65-73. PubMed ID: 28989055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
    Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
    Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.
    Cabalzar K; Pelzer C; Wolf A; Lenz G; Iwaszkiewicz J; Zoete V; Hailfinger S; Thome M
    PLoS One; 2013; 8(8):e72051. PubMed ID: 23977204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.